Logo image of AUR

AURORA INNOVATION INC (AUR) Stock Fundamental Analysis

USA - NASDAQ:AUR - US0517741072 - Common Stock

5.645 USD
-0.18 (-3.01%)
Last: 9/25/2025, 12:02:05 PM
Fundamental Rating

3

Overall AUR gets a fundamental rating of 3 out of 10. We evaluated AUR against 279 industry peers in the Software industry. AUR has a great financial health rating, but its profitability evaluates not so good. AUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year AUR has reported negative net income.
In the past year AUR has reported a negative cash flow from operations.
AUR had negative earnings in each of the past 5 years.
In the past 5 years AUR always reported negative operating cash flow.
AUR Yearly Net Income VS EBIT VS OCF VS FCFAUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

AUR has a worse Return On Assets (-36.59%) than 79.21% of its industry peers.
With a Return On Equity value of -40.68%, AUR is not doing good in the industry: 65.95% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -36.59%
ROE -40.68%
ROIC N/A
ROA(3y)-52.24%
ROA(5y)-42.37%
ROE(3y)-58.86%
ROE(5y)-48.65%
ROIC(3y)N/A
ROIC(5y)N/A
AUR Yearly ROA, ROE, ROICAUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AUR Yearly Profit, Operating, Gross MarginsAUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, AUR has more shares outstanding
AUR has more shares outstanding than it did 5 years ago.
AUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AUR Yearly Shares OutstandingAUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
AUR Yearly Total Debt VS Total AssetsAUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

AUR has an Altman-Z score of 25.32. This indicates that AUR is financially healthy and has little risk of bankruptcy at the moment.
AUR has a better Altman-Z score (25.32) than 94.27% of its industry peers.
There is no outstanding debt for AUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.32
ROIC/WACCN/A
WACCN/A
AUR Yearly LT Debt VS Equity VS FCFAUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

AUR has a Current Ratio of 16.96. This indicates that AUR is financially healthy and has no problem in meeting its short term obligations.
AUR's Current ratio of 16.96 is amongst the best of the industry. AUR outperforms 97.85% of its industry peers.
A Quick Ratio of 16.96 indicates that AUR has no problem at all paying its short term obligations.
AUR has a better Quick ratio (16.96) than 97.85% of its industry peers.
Industry RankSector Rank
Current Ratio 16.96
Quick Ratio 16.96
AUR Yearly Current Assets VS Current LiabilitesAUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

AUR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.08%.
EPS 1Y (TTM)4.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.06% on average over the next years. This is a very strong growth
AUR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 531.08% yearly.
EPS Next Y-3.15%
EPS Next 2Y0.57%
EPS Next 3Y3.9%
EPS Next 5Y22.06%
Revenue Next Year2036.63%
Revenue Next 2Y1328.55%
Revenue Next 3Y1054.83%
Revenue Next 5Y531.08%

3.3 Evolution

AUR Yearly Revenue VS EstimatesAUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2021 2022 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
AUR Yearly EPS VS EstimatesAUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

AUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AUR Price Earnings VS Forward Price EarningsAUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AUR Per share dataAUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.57%
EPS Next 3Y3.9%

0

5. Dividend

5.1 Amount

AUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AURORA INNOVATION INC

NASDAQ:AUR (9/25/2025, 12:02:05 PM)

5.645

-0.18 (-3.01%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners71.66%
Inst Owner Change2.44%
Ins Owners1.33%
Ins Owner Change1.67%
Market Cap10.42B
Analysts74.29
Price Target10.43 (84.77%)
Short Float %11.59%
Short Ratio6.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.16%
Min EPS beat(2)-2.93%
Max EPS beat(2)9.24%
EPS beat(4)2
Avg EPS beat(4)-0.35%
Min EPS beat(4)-12.17%
Max EPS beat(4)9.24%
EPS beat(8)6
Avg EPS beat(8)8.03%
EPS beat(12)8
Avg EPS beat(12)3.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)23.76%
Min Revenue beat(2)-100%
Max Revenue beat(2)147.53%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)40.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10416.89
P/FCF N/A
P/OCF N/A
P/B 5.23
P/tB 7.58
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0
BVpS1.08
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.59%
ROE -40.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.24%
ROA(5y)-42.37%
ROE(3y)-58.86%
ROE(5y)-48.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.86%
Cap/Sales 3000%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.96
Quick Ratio 16.96
Altman-Z 25.32
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)100.51%
Cap/Depr(5y)164.87%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next Y-3.15%
EPS Next 2Y0.57%
EPS Next 3Y3.9%
EPS Next 5Y22.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year2036.63%
Revenue Next 2Y1328.55%
Revenue Next 3Y1054.83%
Revenue Next 5Y531.08%
EBIT growth 1Y-4.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.79%
EBIT Next 3Y7.78%
EBIT Next 5Y22.23%
FCF growth 1Y1.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.93%
OCF growth 3YN/A
OCF growth 5YN/A